Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2014-04-28
Original SEC Filing: Click here

---

Webplus: SVA/20140428/6-K/2_EX-99.1/000.htm SEC Original: v376181_ex99-1.htm
Sinovac Files 2013 Annual Report on Form 20-F The Company will provide a hard copy of its complete audited financial statements to its shareholders upon request, free of charge. Requests for a hard copy of the 2013 Annual Report can be made through the Contact IR page in the Investor Relations section of the Company’s website by submitting complete mailing

---

---

Webplus: SVA/20140428/6-K/3_EX-99.2/000.htm SEC Original: v376181_ex99-2.htm
Sinovac Receives Notification of China Government Grant for EV71 Vaccine Project — RMB 60 Million Free Grant for Construction of Dedicated Production Facility SVA BEIJING, April 24, 2014 — Sinovac Biotech Ltd. (NASDAQ: Enterovirus 71 (EV71) vaccine against hand foot and mouth disease (HFMD). Given the severity of HFMD epidemic levels in China and the government’s focus on developing the

---

---

Webplus: SVA/20140428/6-K/1/000.htm SEC Original: v376181_6k.htm

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2014-04-28CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085